@moon.lejewski's TRT claims need some fact-checking

What did @moon.lejewski actually say?

The entire transcript here is: "You'll ever see in a woman that's just thick. Like, disrespectfully thick." That's it. There's no clinical context, no mechanism explained, no dosage discussed, no hormone named. We're working with a fragment, and it's not clear what the speaker is attributing this body composition change to. The most charitable read, given the TRT category tag, is that they're implying testosterone therapy causes significant body recomposition in women.

To be fair to the creator: we can't fact-check what they didn't say. But the implication, especially in a TRT-tagged video with 38,000 views, carries real weight with real people making real medical decisions.

Does the science back this up?

Sort of, but not in the way this framing suggests. Testosterone does affect body composition in women, but the effects are more nuanced than "disrespectfully thick" implies. The phrase evokes dramatic muscle gain, and that's an overclaim.

Research does show that low-dose testosterone therapy in women can modestly increase lean muscle mass and reduce fat mass, particularly in postmenopausal women or those with documented hypogonadism. Shifren et al. (2000, NEJM) showed testosterone patches improved sexual function and wellbeing in surgically menopausal women, but body recomposition wasn't the primary finding. Davis et al. (2019, Lancet Diabetes and Endocrinology) reviewed testosterone use in women and found evidence for improved muscle strength with supraphysiological doses, but noted significant gaps in long-term safety data. The muscle-building effects at physiological replacement doses are real but modest. You're not looking at a dramatic physique transformation from standard TRT in most women.

What did they get wrong (or right)?

What they got right: testosterone does influence body composition in women. Fat redistribution and modest lean mass increases are documented effects, and this is a legitimate reason some women with hypogonadism pursue hormonal treatment.

What's misleading: the framing implies dramatic, visually striking body changes as a predictable or desirable outcome of TRT. This is an overclaim. Most women on therapeutic-dose testosterone see modest changes that depend heavily on diet, training, genetics, and baseline hormone levels. The "disrespectfully thick" framing also risks glamorizing hormone use for aesthetic purposes rather than medical need, which is a real problem in TRT content online.

• Testosterone in women is only FDA-approved in the U.S. for hypoactive sexual desire disorder in postmenopausal women.
• Using testosterone for aesthetic body recomposition in women is off-label and not without risk.
• Side effects at higher doses include virilization, voice changes, clitoral enlargement, and acne.

What should you actually know?

If you're a woman seeing TRT content and thinking about body composition, here's what the evidence actually says. Testosterone therapy in women with documented low testosterone or hypogonadism can improve lean mass, energy, libido, and mood. These are real, meaningful benefits for the right patient. But "getting thick" is not a medical indication, and chasing aesthetic outcomes with hormones carries risks that short-form content routinely ignores.

The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend against testosterone therapy in women without a clear clinical indication. Before anyone pursues TRT based on social media content, they should get bloodwork, understand their baseline levels, and talk to a provider who actually reads the literature.

FormBlends evaluates each patient individually. Hormones are not a body hack. They're a medical intervention with a benefit-risk calculation that belongs in a clinical conversation, not a TikTok caption.